Homology Medicines: Q2 Earnings Insights

Homology Medicines FIXX reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Homology Medicines beat estimated earnings by 7.27%, reporting an EPS of $-0.51 versus an estimate of $-0.55.

Revenue was down $1.39 million from the same period last year.

Last quarter the company missed on EPS by $0.33 which was followed by a 4.86% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Homology Medicines visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.